These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 17720273

  • 1. Weight gain in type 2 diabetes mellitus--not all uphill.
    Cohen O, Norymberg C, Neumann E, Dekel H.
    Diabetes Res Clin Pract; 2008 Jan; 79(1):128-32. PubMed ID: 17720273
    [Abstract] [Full Text] [Related]

  • 2. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
    Rosendal H, Vondeling H, de Witte LP, Hutubessy RC, van Beekum WT, Heine RJ.
    Ned Tijdschr Geneeskd; 2002 Jan 26; 146(4):166-71. PubMed ID: 11845567
    [Abstract] [Full Text] [Related]

  • 3. [Cardiovascular risk factors and treatment with insulin in type II diabetic patients in whom oral hypoglycemic drugs have failed].
    Calle Pascual AL, Calle Fernández JR.
    Med Clin (Barc); 1993 Jun 26; 101(5):165-7. PubMed ID: 8332008
    [Abstract] [Full Text] [Related]

  • 4. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep 26; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 5. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006 Sep 26; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 6. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
    Dornhorst A, Lüddeke HJ, Sreenan S, Kozlovski P, Hansen JB, Looij BJ, Meneghini L, PREDICTIVE Study Group.
    Int J Clin Pract; 2008 Apr 26; 62(4):659-65. PubMed ID: 18324957
    [Abstract] [Full Text] [Related]

  • 7. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes.
    Heald AH, Kärvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L, Grill V, Cruickshank JK, White A, Gibson JM, Brismar K.
    Am J Med; 2006 Feb 26; 119(2):167.e9-15. PubMed ID: 16443426
    [Abstract] [Full Text] [Related]

  • 8. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C, Hernández Herrero C, Rivas Fernández M.
    Diabet Med; 2008 Aug 26; 25(8):916-23. PubMed ID: 18959604
    [Abstract] [Full Text] [Related]

  • 9. [Hypertension and insulin treatment in type 2 diabetes].
    Ben Salem Hachmi L, Bouguerra R, Maatki O, Smadhi H, Turki Z, Hraoui S, Ben Slama C.
    Arch Mal Coeur Vaiss; 2007 Aug 26; 100(8):664-7. PubMed ID: 17928772
    [Abstract] [Full Text] [Related]

  • 10. Composition of insulin-induced body weight gain in diabetic patients: a bio-impedance study.
    Rigalleau V, Delafaye C, Baillet L, Vergnot V, Brunou P, Gatta B, Gin H.
    Diabetes Metab; 1999 Sep 26; 25(4):321-8. PubMed ID: 10566121
    [Abstract] [Full Text] [Related]

  • 11. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct 26; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 12. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 26; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 13. Effect of insulin treatment on the body composition of Type 2 diabetic patients.
    Sallé A, Guilloteau G, Ryan M, Bouhanick B, Ritz P.
    Diabet Med; 2004 Dec 26; 21(12):1298-303. PubMed ID: 15569132
    [Abstract] [Full Text] [Related]

  • 14. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 26; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 15. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W, Ji Q, Zhu D, Yang J, Chen L, Liu Z, Yu D, Yan L.
    Diabetes Care; 2008 May 26; 31(5):852-6. PubMed ID: 18268073
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB, Fonseca VA, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165
    [Abstract] [Full Text] [Related]

  • 17. Analysis of weight at birth and at diagnosis of childhood-onset type 2 diabetes mellitus in Japan.
    Sugihara S, Sasaki N, Amemiya S, Kohno H, Tanaka T, Matsuura N.
    Pediatr Diabetes; 2008 Jul 28; 9(4 Pt 1):285-90. PubMed ID: 18466207
    [Abstract] [Full Text] [Related]

  • 18. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
    Brancatisano A, Wahlroos S, Matthews S, Brancatisano R.
    Surg Obes Relat Dis; 2008 Jul 28; 4(3):423-9. PubMed ID: 18226973
    [Abstract] [Full Text] [Related]

  • 19. Intensification of therapy and no increase in body mass index with longer disease duration in type 2 diabetes mellitus (ZODIAC-5).
    Logtenberg SJ, Kleefstra N, Ubink-Veltmaat LJ, Houweling ST, Bilo HJ.
    Fam Pract; 2007 Dec 28; 24(6):529-31. PubMed ID: 18039725
    [Abstract] [Full Text] [Related]

  • 20. Glucose homeostasis predicts weight gain: prospective and clinical evidence.
    Boulé NG, Chaput JP, Doucet E, Richard D, Després JP, Bouchard C, Tremblay A.
    Diabetes Metab Res Rev; 2008 Feb 28; 24(2):123-9. PubMed ID: 17879957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.